Top

Atlas Genetics has developed novel, robust and extremely sensitive methods for the rapid detection of DNA.

Our point-of-care Velox™ platform will perform a DNA analysis from a clinical sample such as blood or urine within 25 minutes using a discrete test cartridge inserted into a small instrument. This makes the holy grail of “test and treat” attainable.

Clinicians, nurses and vets will be able to make immediate assessments of patients and advise or administer treatment at a first assessment. Critically the technology, and associated instrumentation required, will be small, simple and low cost, opening up a range of out-of-lab markets that have previously been unavailable.

Atlas’ technology is generic and can be applied to any condition where DNA or RNA detection can be used to identify an infectious micro-organism or determine the correct drug prescribing regime .

We are currently developing assays for the Velox™ platform for the diagnosis of:

Human

  • Chlamydia / Gonorrhoea
  • MRSA
  • Group B Streptococcus
  • Bacterial Meningitis
  • Norwalk Viruses

Equine

  • Respiratory infections including Strangles